피메이시스(FEMY)는 NAS에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $2.59 (+1.57%), 시가총액 $21.54M.
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution.
피메이시스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
피메이시스의 현재 주가는 $2.59 (+1.57%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
피메이시스의 시가총액은 약 $21.54M입니다.
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally.